Chrysalis settles Revolution Beauty claim

Chrysalis sold its position in Revolution Beauty, which it had bought for £45m, for a near 90% loss in 2022

1 minute

Chrysalis Investments has settled a potential claim made against former holding Revolution Beauty.

In a stock exchange announcement this morning (2 January), the two parties said they had reached a confidential settlement without any admission of liability. Chrysalis had previously alleged Revolution had provided misleading information during its period as a shareholder.

Last February, Chrysalis outlined ‘potential claims’ against Revolution Beauty under the UK financial services & markets act.

See also: Chrysalis preps for £100m share buyback with new loan

Chrysalis, which invests in later-stage private equity firms, bought £45m worth of Revolution shares in July 2021.

The investment trust took heavy losses on its stake, selling its position for £5.7m in late 2022.

The investment trust’s claim centred around information provided by Revolution during Chrysalis’s time as a shareholder, which it said contained ‘misstatements and material omissions’.

Revolution strongly contested those claims.

The Revolution board said it had agreed to pay Chrysalis a ‘non-material sum’, believed to be less than 1% of Chrysalis’s £613m market cap.

According to the AIC, Chrysalis shares currently trade at a -23.6% discount to NAV.